相关实验视频
Updated: Jul 1, 2025

12:08
Improving IV Insulin Administration in a Community Hospital
Published on: June 11, 2012
18.8K
药剂师领导的社区群体教育计划在改善糖尿病管理方面的有效性:多中心随机对照试验
Kamarudin Ahmad1, Lawrence Anchah2, Chuo Yew Ting3
1Miri Hospital and Clinical Research Center Miri, Miri, Sarawak, Malaysia.
Contemporary clinical trials communications
|March 4, 2024
概括
药房综合社区护理 (PICC) 计划旨在改善马来西亚2型糖尿病患者的血红蛋白A1c (HbA1c) 和糖尿病知识. 这项随机对照试验将评估PICC计划.
科学领域:
- 药理学和公共卫生
背景情况:
- 2型糖尿病 (T2DM) 在全球和马来西亚构成重大健康负担.
- 有效的管理策略对于改善血糖控制和患者治疗结果至关重要.
研究的目的:
- 引入和评估药店综合社区护理 (PICC) 计划.
- 在T2DM患者中增强血红蛋白A1c (HbA1c) 水平和糖尿病 (DM) 知识.
- 评估在马来西亚萨拉瓦克的一个结构化,由药剂师领导的干预措施的有效性.
主要方法:
- 一个前性的,多中心的,随机对照试验,并行设计.
- 两组 (每组n=47) 将参与:干预 (PICC计划) 和控制 (标准护理).
- 该PICC计划包括四个由药剂师指导的小组会议,重点是药物坚持和DM管理.
主要成果:
- 主要结果包括改善糖尿病药物管理知识和坚持.
- 二次结果是HbA1c水平的变化.
- 数据收集期间:2023年5月1日至12月31日. 试验注册:NCT05106231.1. 试验注册:NCT05106231.1. 试验注册:NCT05106231.1. 试验注册:NCT05106231.1. 试验注册:NCT05106231.1. 试验注册:NCT05106231.1. 试验注册:NCT05106231. 试验注册:NCT05106231.
结论:
- 该PICC计划显示了改善T2DM患者健康状况的潜力.
- 成功实施可能会导致更有效的基于社区的糖尿病管理.
- 提高患者的知识和坚持可以促进更好的健康实践.
更多相关视频
相关概念视频
Diabetes: Management and Pharmacotherapy
282
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
282
Diabetes Mellitus: Type 2 and Gestational
2.4K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.4K
Diabetes Mellitus: Overview and Type I Subtype
2.6K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
2.6K
Insulin: Dosing Regimen and Adverse Effects
170
Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
170
Oral Hypoglycemic Agents: Biguanides and Glitazones
199
Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood...
199
Community Based Intervention
43
Community-based interventions in mental health represent a paradigm shift from institution-centered care to treatments embedded within the fabric of local communities. By prioritizing inclusion and leveraging existing societal structures, this approach fosters a supportive environment conducive to addressing mental health challenges while promoting individual dignity and agency.
Foundations of Community Mental Health Programs
Central to the success of community-based interventions is the...
Foundations of Community Mental Health Programs
Central to the success of community-based interventions is the...
43

